Precision Business Insights (PBI) in its report titled “Europe Influenza Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.The Europe influenza market size was accounted for US$ -- Mn in 2018 and anticipated to account for US$ -- Mn by 2025. Increased prevalence of upper respiratory diseases will create a demand for Europe influenza market. Increase in vaccination awareness, rising investment by companies in research and development activities, and increasing number of immunization programs organized by the government are the major factors fuelling the growth of Europe influenza market over the forecast period.
Europe influenza market segmented on the basis of product type, route of administration, distribution channel, and end user.
Request Sample Report:
[URL]https://precisionbusinessinsights.com/request-sample?product_id=15854[/URL]
Hospitals and Clinics Will Dominate the Revenue Share.
Based on end-user type, body contouring devices market segmented into medical spas, beauty centers and dermatology clinics. The hospitals and clinics are witnessed to account for major revenue share over the forecast period due to advanced research and technology.
Europe Holds a Dominant Share in the Global Influenza Market
Europe holds a dominant share in the global influenza market. The largest share is attributed to rising awareness regarding the influenza virus and disease, raising investment by companies in research and development, and increasing number of immunization programs organized by the government are some of the factors driving the Europe Influenza Market. The increase in the prevalence of influenza in the European region is a major driving factor for the growth of European Influenza market. According to EMEA, approximately 15,000 people of the severe consequence of influenza.
Novel Inventions of Influenza Vaccine Play Vital Role in Europe Influenza Market
Innovative inventions of influenza vaccine play an important role in the development of the market. For instance, in June 2016, new four-strain influenza vaccine, Vaxigriptetra, regulatory dossier from Sanofi Pasteur approved in Europe.
Key players in the market include AstraZeneca (U.K.), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline Plc. (U.K.), Novartis AG (Switzerland), Sanofi (France), Protein Sciences Corporation (U.S.), Emergent Biosolutions (U.S.), BioCryst Pharmaceuticals.Inc. (U.S.), and Abbott Laboratories Inc. (U.S.) to name a few.
Detailed Segmentation
By Drug Class
o Antiviral drugs
? Zanamivir
? Oseltamivir
? Amantadine
? Rimantadine
? Others
o Interferons
o Vaccines
? Trivalent
? Quadrivalent
By Route of Administration
o Oral
o Parental
o Others
By End-User Type
o Hospital pharmacies
o Retail pharmacies
o Others
By Geography
o Europe
? Germany
? UK
? France
? Russia
? Spain
? Italy
? Rest of Europe
For More Information:
[URL]https://precisionbusinessinsights.com/market-reports/europe-influenza-market/[/URL]